$10.00
-0.390 (-3.75%)
At Close: Jul 31, 2026
Sysmex (OTCMKTS:SSMXY) Downgraded by Daiwa Capital Markets
07:20am, Monday, 29'th Nov 2021 Dakota Financial News
Daiwa Capital Markets lowered shares of Sysmex (OTCMKTS:SSMXY) from an outperform rating to a neutral rating in a research report sent to investors on Friday, The Fly reports. A number of other equities research analysts have also issued reports on the company. Zacks Investment Research raised Sysmex from a sell rating to a hold rating []
Daiwa Capital Markets Lowers Sysmex (OTCMKTS:SSMXY) to Neutral
12:12pm, Friday, 26'th Nov 2021 Transcript Daily
Sysmex (OTCMKTS:SSMXY) was downgraded by equities research analysts at Daiwa Capital Markets from an outperform rating to a neutral rating in a research report issued to clients and investors on Friday, The Fly reports. Several other research analysts have also issued reports on the company. Zacks Investment Research upgraded Sysmex from a sell rating to []
Vitro Diagnostics Reagents Market Demand Analysis To 2027 Lead By- Roche, Siemens, Abbott, Danaher, Thermo Fisher, BioMerieux, Sysmex Corporation
07:16am, Thursday, 25'th Nov 2021 OpenPR
The "Vitro Diagnostics Reagents" Market report offers qualitative and quantitative insights and a detailed analysis of market size & growth rate for all possible segments in the market. The Global Vitro Diagnostics Reagents Industry presents a market overview, product details,
Breast Cancer Liquid Biopsy Market report examines all the Major factors persuading the growth of the Breast Cancer Liquid Biopsy market, which includes demand-supply scenario, cost structure, profit margins, manufacture, and value chain study. Regional valuation of Breast Cancer Liquid
Cancer Diagnostics Market revenue to cross USD 207.9 Bn by 2027: Global Market Insights Inc.
07:30am, Monday, 22'nd Nov 2021 Intrado Digital Media
Major cancer diagnostics market players include Abbott, Biocartis, Becton, Dickinson and Company, Janssen Diagnostic LLC, GE Healthcare, Siemens Healthineers, and Sysmex Corporation. Major cancer diagnostics market players include Abbott, Biocartis, Becton, Dickinson and Company, Janssen Diagnostic LLC, GE Healthcare, Siemens Healthineers, and Sysmex Corporation.
Sysmex (OTCMKTS:SSMXY) Trading Up 1.9%
06:14am, Friday, 19'th Nov 2021 Dakota Financial News
Sysmex Co. (OTCMKTS:SSMXY) was up 1.9% on Thursday . The stock traded as high as $64.15 and last traded at $64.00. Approximately 26,635 shares were traded during trading, an increase of 32% from the average daily volume of 20,172 shares. The stock had previously closed at $62.80. Several equities analysts have weighed in on SSMXY []
Rapid Coagulation Analyzers Market to Represent Healthy Growth by 2027 & COVID-19 Impact | Roche, Sysmex
01:27pm, Wednesday, 17'th Nov 2021 OpenPR
Crafting a beneficial marketing strategy is easy with this unique Rapid Coagulation Analyzers market analysis. It helps market players in better understanding of target market of the company. By knowing target market, launchings of better products and expanding the business
Sign In
Buy SSMXY